The relationship between CFTR genotypes and functional severity of pulmonary disease in CF has been proven to be difficult to establish. In contrast to previous modelling concepts we stratified genotypes according to the nature of mutations in combination with and without F508del and searched for associations with different lung function parameters (FRC pleth , LCI, V TG , sR eff , FEV 1 , FEF 50 ) Methods: Longitudinal data included repeated measurements of 246 CF patients (124 males; 122 females) aged between 5 and 18 years annually seen between 1987 and 2010. Linear mixed model (LMM) analyses were used to analyse the relationship between each lung function parameter regarding progression with age (slope) and specific genotypes: A. F508del(2); n = 144 vs. F508del_frameshift; n = 27 vs. nonF508del_frameshift; n = 10 B. F508del(2); n = 144 vs. F508del_nonsense; n = 27 vs. nonF508del_nonsense; n = 11 C. F508del(2); n = 144 vs. F508del_missense; n = 10 vs. nonF508del_missense; n = 9 Results: The degree of bronchial obstruction (sR eff ) significantly (p < 0.01) decreased with age in nonF508del_frameshift genotypes, ventilation inhomogeneities (LCI) and bronchial obstruction were less pronounced in nonF508del_nonsense groupe, and increase of bronchial obstruction as well as decline in flow limitation (FEV 1 , MEF 50 ) were significantly lower in nonF508del_missense patients. Conclusions: Nature and combination with or without F508del are important stratifying criteria for genotype-phenotype modelling in CF. Extended lung function evaluation is crucial to provide reliable estimate of disease progression and to allow prognostic conclusions.
Background:
We recently demonstrated that: (1) the Wisconsin x-ray scoring system (WCXR) is highly sensitive to chest CT abnormalities for chest x-rays obtained within one year of the CT; (2) WCXR scores are strongly predictive of WCXR and FEV 1 severity 5−7 years later. In this study, we hypothesize that WCXR scores obtained up to 5 years before and after a chest CT would be correlated with the Brody CT score. Methods: In 2000, 81 subjects in the Wisconsin Randomized Control Trial of CF Newborn Screening obtained a high-resolution chest CT at their clinical baseline. Chest x-rays and spirometry were performed annually. The sensitivity, ROC, and correlation between the 2000 Brody CT score and annual WCXR and FEV 1 % predicted obtained between 5 years before and 5 years after the chest CT were calculated. Results: In 2000, the mean (range) age was 11.6 (6.6-17.6) years. During the 10-year study period, the mean (SD) WCXR worsened from 10.2 (9.6) to 23.4 (14.5); the mean (SD) FEV 1 % predicted remained stable: 91.8 (23.4) in the first year and 92.3 (18.3) in the last year. The correlation between WCXR scores and the CT score ranged from 0.72 to 0.84. In contrast, the correlation between FEV 1 and CT scores ranged from −0.49 to −0.76. The WCXR correlation was statistically significantly better than the FEV 1 correlation in the 4 years before the CT and years 2−4 after. Conclusion: There is a strong correlation between annual WCXR scores and chest CT score for a period up to 5 years before and 5 years after the CT. Over a 10-year period, longitudinal WCXR scores compare favorably with chest CT and provide more prognostic information on lung disease progression than does FEV 1 . 
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